COVID-19 Clinical footprint to infer about mortality
share
Information of 1.6 million patients identified as SARS-CoV-2 positive in Mexico is used to understand the relationship between comorbidities, symptoms, hospitalizations and deaths due to the COVID-19 disease. Using the presence or absence of these latter variables a clinical footprint for each patient is created. The risk, expected mortality and the prediction of death outcomes, among other relevant quantities, are obtained and analyzed by means of a multivariate Bernoulli distribution. The proposal considers all possible footprint combinations resulting in a robust model suitable for Bayesian inference.
READ FULL TEXT